Diabetes may worsen cancer treatment experience, new study investigates
NCT ID NCT07466212
Summary
This study aims to understand how having type 2 diabetes affects the quality of life of cancer patients receiving immunotherapy. Researchers will follow 920 patients for six months, comparing survey responses from those with and without diabetes. The goal is to see if diabetes adds extra challenges during cancer treatment and affects how patients feel overall.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Afdeling for Kræftbehandling, Herlev Hospital
Herlev, 2730, Denmark
Contact Email: •••••@•••••
-
Kræftafdelingen, Aarhus Universitetshospital
Aarhus, 8000, Denmark
Contact
Contact Email: •••••@•••••
-
Onkologisk afdeling, Klinik Kirurgi og Kræftbehandling
Aalborg, 9000, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Sygehus Lillebælt, Onkologisk afdeling Vejle
Vejle, 7100, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.